doi: 10.1016/0006-2952(79)90027-3.
Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents
- PMID: 229856
- DOI: 10.1016/0006-2952(79)90027-3
Item in Clipboard
Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents
Biochem Pharmacol.
.
No abstract available
Similar articles
-
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.J Med Chem. 1979 Jan;22(1):36-9. doi: 10.1021/jm00187a009. J Med Chem. 1979. PMID: 423181
-
Role of the quinone structure in the mitochondrial damage induced by antitumor anthracyclines. Comparison of adriamycin and 5-iminodaunorubicin.FEBS Lett. 1983 May 8;155(2):267-72. doi: 10.1016/0014-5793(82)80618-2. FEBS Lett. 1983. PMID: 6852236
-
[Morphological and ultrastructural indicators of early cardiotoxicity in rats after the administration of rubidomycin and its derivatives].Patol Pol. 1984 Oct-Dec;35(4):453-79. Patol Pol. 1984. PMID: 6535952 Polish. No abstract available.
-
Anthracycline mechanisms in analogue selection.Drugs Exp Clin Res. 1985;11(1):1-8. Drugs Exp Clin Res. 1985. PMID: 3915272 Review.
-
Cardiac safety of liposomal anthracyclines.Oncologist. 2003;8 Suppl 2:17-24. doi: 10.1634/theoncologist.8-suppl_2-17. Oncologist. 2003. PMID: 13679592 Review.
Cited by
-
The electrochemistry of quinizarin revealed through its mediated reduction of oxygen.Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):19891-5. doi: 10.1073/pnas.1113615108. Epub 2011 Nov 22. Proc Natl Acad Sci U S A. 2011. PMID: 22109547 Free PMC article.
-
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci. 1986 Apr 25;8(2):109-33. doi: 10.1007/BF02086146. Pharm Weekbl Sci. 1986. PMID: 3520474 Review.
-
The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.Pharmacogenomics. 2012 Aug;13(11):1257-69. doi: 10.2217/pgs.12.102. Pharmacogenomics. 2012. PMID: 22920396 Free PMC article. Review.
-
Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.Drugs. 1991 Oct;42(4):690-719. doi: 10.2165/00003495-199142040-00010. Drugs. 1991. PMID: 1723369 Review.
-
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.Cancer Chemother Pharmacol. 1989;23(1):8-14. doi: 10.1007/BF00258450. Cancer Chemother Pharmacol. 1989. PMID: 2909292
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
